169 related articles for article (PubMed ID: 37977042)
1. A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer.
Hu A; Wang H; Xu Q; Pan Y; Jiang Z; Li S; Qu Y; Hu Y; Wu H; Wang X
Redox Biol; 2023 Dec; 68():102959. PubMed ID: 37977042
[TBL] [Abstract][Full Text] [Related]
2. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH
Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871
[TBL] [Abstract][Full Text] [Related]
3. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
4. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
5. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation.
Huang Y; Wang F; Lin X; Li Q; Lu Y; Zhang J; Shen X; Tan J; Qin Z; Chen J; Chen X; Pan G; Wang X; Zeng Y; Yang S; Liu J; Xing F; Li K; Zhang H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221653120. PubMed ID: 37788309
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Wang L; Li C; Song Y; Yan Z
Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
[TBL] [Abstract][Full Text] [Related]
7. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Schlaepfer IR; Joshi M
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex.
Lee K; Kerner J; Hoppel CL
J Biol Chem; 2011 Jul; 286(29):25655-62. PubMed ID: 21622568
[TBL] [Abstract][Full Text] [Related]
9. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.
Xu R; Liu Y; Ma L; Sun Y; Liu H; Yang Y; Jin T; Yang D
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):758-768. PubMed ID: 37249337
[TBL] [Abstract][Full Text] [Related]
10. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Peng S; Chen D; Cai J; Yuan Z; Huang B; Li Y; Wang H; Luo Q; Kuang Y; Liang W; Liu Z; Wang Q; Cui Y; Wang H; Liu X
Mol Oncol; 2021 May; 15(5):1391-1411. PubMed ID: 33528867
[TBL] [Abstract][Full Text] [Related]
11. Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Ricciardi MR; Mirabilii S; Allegretti M; Licchetta R; Calarco A; Torrisi MR; Foà R; Nicolai R; Peluso G; Tafuri A
Blood; 2015 Oct; 126(16):1925-9. PubMed ID: 26276667
[TBL] [Abstract][Full Text] [Related]
12. iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Lin D; Zhang H; Liu R; Deng T; Ning T; Bai M; Yang Y; Zhu K; Wang J; Duan J; Ge S; Sun B; Ying G; Ba Y
Mol Oncol; 2021 Dec; 15(12):3430-3446. PubMed ID: 34213835
[TBL] [Abstract][Full Text] [Related]
13. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.
Tang M; Dong X; Xiao L; Tan Z; Luo X; Yang L; Li W; Shi F; Li Y; Zhao L; Liu N; Du Q; Xie L; Hu J; Weng X; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Cell Death Dis; 2022 Apr; 13(4):331. PubMed ID: 35411000
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil trafficking to the site of infection requires Cpt1a-dependent fatty acid β-oxidation.
Pham L; Komalavilas P; Eddie AM; Thayer TE; Greenwood DL; Liu KH; Weinberg J; Patterson A; Fessel JP; Boyd KL; Schafer JC; Kuck JL; Shaver AC; Flaherty DK; Matlock BK; Wijers CDM; Serezani CH; Jones DP; Brittain EL; Rathmell JC; Noto MJ
Commun Biol; 2022 Dec; 5(1):1366. PubMed ID: 36513703
[TBL] [Abstract][Full Text] [Related]
15. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
16. CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo.
Xie Y; Yuan Q; Tang B; Xie Y; Cao Y; Qiu Y; Zeng J; Wang Z; Su H; Zhang C
Diabetes; 2024 Jun; 73(6):879-895. PubMed ID: 38506804
[TBL] [Abstract][Full Text] [Related]
17. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
[No Abstract] [Full Text] [Related]
18. Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.
Sawyer BT; Qamar L; Yamamoto TM; McMellen A; Watson ZL; Richer JK; Behbakht K; Schlaepfer IR; Bitler BG
Mol Cancer Res; 2020 Jul; 18(7):1088-1098. PubMed ID: 32198139
[TBL] [Abstract][Full Text] [Related]
19. PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
Du Q; Tan Z; Shi F; Tang M; Xie L; Zhao L; Li Y; Hu J; Zhou M; Bode A; Luo X; Cao Y
Cancer Sci; 2019 Jun; 110(6):2050-2062. PubMed ID: 30945396
[TBL] [Abstract][Full Text] [Related]
20. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
